408 Followers on Owler
OverviewCompetitorsNews & Insights

Cadila Pharmaceuticals Competitors or Alternatives

Cadila Pharmaceuticals's top competitors include Intas, Solara and Titan Pharma.

Unlock 7 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Cadila Pharmaceuticals's company profile

Rajiv I. Modi

Managing Director

76/100
5,000 - 10,000
$0
$1B - 5B
  • $0
    $1B - 5B
  • 5,000 - 10,000
    $0
  • $1B - 5B
  • 76/100
  • 5,000 - 10,000
  • $0
  • $1B - 5B
View ProfileView
1
Cadila Pharmaceuticals's Competitor - Intas logo

Binish Chudgar

Managing Director

90/100
10,000 - 50,000
$239M
$1B - 5B
  • $239M
    $1B - 5B
  • 10,000 - 50,000
    $239M
  • $1B - 5B
  • 90/100
  • 10,000 - 50,000
  • $239M
  • $1B - 5B
View ProfileView
2
Cadila Pharmaceuticals's Competitor - Solara logo

Sandeep Rao

Managing Director & CEO

- -
2,156
$30M
$151.3M
  • $30M
    $151.3M
  • 2,156
    $30M
  • $151.3M
  • - -
  • 2,156
  • $30M
  • $151.3M
View ProfileView
3
Cadila Pharmaceuticals's Competitor - Titan Pharma logo

Piyush Shah

Managing Director

85/100
1 - 25
- -
$5M - 25M
  • - -
    $5M - 25M
  • 1 - 25
    - -
  • $5M - 25M
  • 85/100
  • 1 - 25
  • - -
  • $5M - 25M
View ProfileView
4
Cadila Pharmaceuticals's Competitor - Reliance Life Sciences logo

K.V. Subramaniam

President & CEO

67/100
1,000 - 5,000
- -
$100M - 500M
  • - -
    $100M - 500M
  • 1,000 - 5,000
    - -
  • $100M - 500M
  • 67/100
  • 1,000 - 5,000
  • - -
  • $100M - 500M
View ProfileView
5
Cadila Pharmaceuticals's Competitor - Lupin logo

Vinita Gupta

CEO

73/100
20,789
$25M
$2.6B
  • $25M
    $2.6B
  • 20,789
    $25M
  • $2.6B
  • 73/100
  • 20,789
  • $25M
  • $2.6B
View ProfileView
The top 10 competitors in Cadila Pharmaceuticals' competitive set are Intas, Solara, Titan Pharma, Dr.Reddy's, Reliance Life Sciences, Lupin, Aurobindo Pharma, Laborate, NEXGEN and Cooper Pharma. Together they have raised over 297.4M between their estimated 102.0K employees. Cadila Pharmaceuticals's revenue is the ranked 4th among it's top 10 competitors. The top 10 competitors average 1.4B. Cadila Pharmaceuticals has 8,000 employees and is ranked 5th among it's top 10 competitors. The top 10 competitors average 10,001.

Cadila Pharmaceuticals VS Intas

Intas is Cadila Pharmaceuticals's #1 competitor. Intas's headquarters is in Ahmedabad, Gujarat, and was founded in 1976. Like Cadila Pharmaceuticals, Intas also works within the Health Care Equipment & Services sector. Intas generates 100% of Cadila Pharmaceuticals's revenue.

Cadila Pharmaceuticals VS Solara

Solara is one of Cadila Pharmaceuticals's top rivals. Solara was founded in Chennai, Tamil Nadu} in 2017. Solara operates in the Medical Research & Laboratories industry. Compared to Cadila Pharmaceuticals, Solara generates $2.3B less revenue.

Looking for similar companies to Cadila Pharmaceuticals?

Similar Companies

Companies in ahmedabad with revenue in $1.0-5.0B range

See 11 companies 
Companies in Gujarat with revenue in $1.0-5.0B range

See 16 companies 
Companies in ahmedabad with employees in 5.0-10K range

See 11 companies 
Companies in Gujarat with employees in 5.0-10K range

See 25 companies 
Health Care Services companies in ahmedabad

See 94 companies 
Health Care Equipment & Services companies in ahmedabad

See 172 companies 
Health Care Services companies with employees in 5.0-10K range

See 179 companies 
Health Care Services companies in Gujarat

See 255 companies 
Health Care Services companies with revenue in $1.0-5.0B range

See 286 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Cadila Pharmaceuticals and Cadila Pharmaceuticals's Competitors

April 24, 2025The Hindu
April 24, 2025The Hindu
Aurobindo Pharma's Eugia Pharma has been approved the U.S. FDA to manufacture Dasatinib Tablets, a bioequivalent to Bristol-Myers Squibb's Sprycel...
April 25, 2025FinanzNachrichten
Up to five-year contract extension to support the WFH Humanitarian Aid Program with medicine donations and financial assistanceSTOCKHOLM, April 25, 202...
April 24, 2025Yahoo
In This Article: GALWAY , Ireland , April 24, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced...
April 25, 2025Proactive Investors
First-quarter results from GSK PLC (LSE:GSK, NYSE:GSK) will focus on commentary around the outlook, including interpretation of US policy changes under...
April 24, 2025IndiaMedToday
HPE Private Cloud Enterprise will enhance scalability and operational performance for Lupin Hewlett Packard Enterprise announced that Mumbai-based Lupi...
April 24, 2025Marketscreener
Sanofi reported earnings results for the first quarter ended March 31, 2025. For the first quarter, the company reported sales was EUR 9,895 million co...
April 24, 2025Zacks
Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeSty...
April 24, 2025Business Standard
Thus far in the calendar year 2025, the stock price of GSK Pharma has zoomed 40 per cent, as against 1.8 per cent rise in BSE Sensex....
April 25, 2025The Hindu Business Line
Multiple drug price reductions bring BPaLM treatment regimen price down 47 percent, at $310, since December 2022....

Frequently Asked Questions about Cadila Pharmaceuticals

  1. Who are Cadila Pharmaceuticals's top competitors?

    Cadila Pharmaceuticals's top 3 competitors are Intas, Solara, Titan Pharma.

  2. Who is similar to Cadila Pharmaceuticals?

    Intas is the most similar to Cadila Pharmaceuticals. Solara and Titan Pharma are also similar to Cadila Pharmaceuticals.

  1. Are Cadila Pharmaceuticals and Intas competitors?

    Yes, Intas is one of Cadila Pharmaceuticals’s top competitors.